Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Rom J Intern Med ; 49(2): 137-44, 2011.
Article in English | MEDLINE | ID: mdl-22303605

ABSTRACT

We present the case of a patient with a double transformation during the evolution of chronic hematopoietic malignancy - JAK2 positive chronic myeloproliferative neoplasm; the first transformation had occurred previous to the presentation in our Department, but the second transformation was observed in evolution and it was into a rapidly evolving disease, followed by survival of less than one month. We underline the very poor prognosis -- overall survival of 2.5 years from initial presentation -- a much reduced survival for a chronic myeloproliferative neoplasm, probably due also to multiple associated pathology. Also, the other interesting element of the case is related to the dysfunctional platelets -- hemorrhagic complication at increased platelet count, respectively thrombosis at platelet count under 20000/mmc.


Subject(s)
Cell Transformation, Neoplastic , Leukemia, Myeloid, Acute/diagnosis , Polycythemia Vera/diagnosis , Primary Myelofibrosis/diagnosis , Aged, 80 and over , Antineoplastic Agents/therapeutic use , Biomarkers/blood , Chronic Disease , Fatal Outcome , Humans , Janus Kinase 2/genetics , Leukemia, Myeloid, Acute/drug therapy , Leukemia, Myeloid, Acute/enzymology , Leukemia, Myeloid, Acute/genetics , Male , Mutation , Platelet Count , Polycythemia Vera/drug therapy , Polycythemia Vera/enzymology , Polycythemia Vera/genetics , Primary Myelofibrosis/drug therapy , Primary Myelofibrosis/enzymology , Primary Myelofibrosis/genetics , Prognosis , Pulmonary Embolism/diagnosis , Risk Factors , Splenomegaly , Thrombocytosis/diagnosis , Venous Thromboembolism/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...